147 related articles for article (PubMed ID: 31848194)
1. Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
Tan S; Xu Y; Wang Z; Wang T; Du X; Song X; Guo X; Peng J; Zhang J; Liang Y; Lu J; Peng J; Gao C; Wu Z; Li C; Li N; Gao L; Liang X; Ma C
Cancer Res; 2020 Mar; 80(5):1130-1142. PubMed ID: 31848194
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients.
Chen Y; Zhang W; Cheng M; Hao X; Wei H; Sun R; Tian Z
Viruses; 2024 May; 16(5):. PubMed ID: 38793619
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model.
Chen M; Xu M; Zhu C; Wang H; Zhao Q; Zhou F
Cancer Immunol Immunother; 2019 Jun; 68(6):961-971. PubMed ID: 30955067
[TBL] [Abstract][Full Text] [Related]
4. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Sun C; Sun H; Zhang C; Tian Z
Cell Mol Immunol; 2015 May; 12(3):292-302. PubMed ID: 25308752
[TBL] [Abstract][Full Text] [Related]
5. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
Zecca A; Barili V; Canetti D; Regina V; Olivani A; Carone C; Capizzuto V; Zerbato B; Trenti T; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cancer Immunol Immunother; 2020 Aug; 69(8):1589-1603. PubMed ID: 32307580
[TBL] [Abstract][Full Text] [Related]
6. Porcine TLR8 signaling and its anti-infection function are disturbed by immune checkpoint receptor TIM-3 via inhibition of P13K-AKT pathway.
Zheng W; Ao D; Cao Q; Liu A; Lv M; Sun Z; Zhang H; Zheng W; Chen N; Zhu J
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132018. PubMed ID: 38702002
[TBL] [Abstract][Full Text] [Related]
7. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the
Kristenson L; Badami C; Ljungberg A; Islamagic E; Tian Y; Xie G; Hussein BA; Pesce S; Tang KW; Thorén FB
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2316447121. PubMed ID: 38557174
[TBL] [Abstract][Full Text] [Related]
9. T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
Kojima H; Kadono K; Hirao H; Dery KJ; Torgerson T; Yao S; Kaldas FM; Farmer DG; Blumberg RS; Kupiec-Weglinski JW
Gastroenterology; 2023 Nov; 165(5):1233-1248.e9. PubMed ID: 37479191
[TBL] [Abstract][Full Text] [Related]
10. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.
Gonçalves Silva I; Yasinska IM; Sakhnevych SS; Fiedler W; Wellbrock J; Bardelli M; Varani L; Hussain R; Siligardi G; Ceccone G; Berger SM; Ushkaryov YA; Gibbs BF; Fasler-Kan E; Sumbayev VV
EBioMedicine; 2017 Aug; 22():44-57. PubMed ID: 28750861
[TBL] [Abstract][Full Text] [Related]
11. Liver natural killer cells: subsets and roles in liver immunity.
Peng H; Wisse E; Tian Z
Cell Mol Immunol; 2016 May; 13(3):328-36. PubMed ID: 26639736
[TBL] [Abstract][Full Text] [Related]
12. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion.
Yıldırım C
Mol Biol Rep; 2024 Apr; 51(1):571. PubMed ID: 38662155
[TBL] [Abstract][Full Text] [Related]
13. Activin A, a Novel Chemokine, Induces Mouse NK Cell Migration via AKT and Calcium Signaling.
Wang Y; Liu Z; Qi Y; Wu J; Liu B; Cui X
Cells; 2024 Apr; 13(9):. PubMed ID: 38727264
[TBL] [Abstract][Full Text] [Related]
14. Tissue damage from chronic liver injury inhibits peripheral NK cell abundance and proinflammatory function.
You Z; Ling S; Zhao S; Han H; Bian Y; He Y; Chen X
J Leukoc Biol; 2024 May; 115(6):1042-1052. PubMed ID: 38315633
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of CD73 on human natural killer cells.
Chambers AM; Wang J; Dao TN; Lupo KB; Veenhuis P; Ayers MG; Slivova V; Cohen-Gadol AA; Matosevic S
Cancer Immunol Immunother; 2022 Dec; 71(12):3043-3056. PubMed ID: 35622118
[TBL] [Abstract][Full Text] [Related]
16. The role of TIM-3 in sepsis: a promising target for immunotherapy?
Wang C; Liu J; Wu Q; Wang Z; Hu B; Bo L
Front Immunol; 2024; 15():1328667. PubMed ID: 38576606
[TBL] [Abstract][Full Text] [Related]
17. Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.
Engelskircher SA; Chen PC; Strunz B; Oltmanns C; Ristic T; Owusu Sekyere S; Kraft ARM; Cornberg M; Wirth T; Heinrich B; Björkström NK; Wedemeyer H; Woller N
Hepatology; 2024 Feb; ():. PubMed ID: 38381525
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
[TBL] [Abstract][Full Text] [Related]
19. NK cells for cancer immunotherapy.
Shimasaki N; Jain A; Campana D
Nat Rev Drug Discov; 2020 Mar; 19(3):200-218. PubMed ID: 31907401
[TBL] [Abstract][Full Text] [Related]
20. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.
Bald T; Krummel MF; Smyth MJ; Barry KC
Nat Immunol; 2020 Aug; 21(8):835-847. PubMed ID: 32690952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
